17-80110708-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000152.5(GAA):​c.1438-19G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.706 in 1,610,108 control chromosomes in the GnomAD database, including 405,650 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.66 ( 33489 hom., cov: 33)
Exomes 𝑓: 0.71 ( 372161 hom. )

Consequence

GAA
NM_000152.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.190

Publications

18 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, G2P
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 3 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-80110708-G-C is Benign according to our data. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80110708-G-C is described in CliVar as Benign. Clinvar id is 92464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAANM_000152.5 linkc.1438-19G>C intron_variant Intron 9 of 19 ENST00000302262.8 NP_000143.2 P10253

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAAENST00000302262.8 linkc.1438-19G>C intron_variant Intron 9 of 19 1 NM_000152.5 ENSP00000305692.3 P10253

Frequencies

GnomAD3 genomes
AF:
0.655
AC:
99623
AN:
151992
Hom.:
33476
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.531
Gnomad AMI
AF:
0.649
Gnomad AMR
AF:
0.557
Gnomad ASJ
AF:
0.770
Gnomad EAS
AF:
0.538
Gnomad SAS
AF:
0.661
Gnomad FIN
AF:
0.775
Gnomad MID
AF:
0.842
Gnomad NFE
AF:
0.736
Gnomad OTH
AF:
0.667
GnomAD2 exomes
AF:
0.670
AC:
167242
AN:
249778
AF XY:
0.684
show subpopulations
Gnomad AFR exome
AF:
0.532
Gnomad AMR exome
AF:
0.475
Gnomad ASJ exome
AF:
0.780
Gnomad EAS exome
AF:
0.528
Gnomad FIN exome
AF:
0.764
Gnomad NFE exome
AF:
0.740
Gnomad OTH exome
AF:
0.721
GnomAD4 exome
AF:
0.712
AC:
1037728
AN:
1457998
Hom.:
372161
Cov.:
33
AF XY:
0.713
AC XY:
517085
AN XY:
725436
show subpopulations
African (AFR)
AF:
0.534
AC:
17822
AN:
33394
American (AMR)
AF:
0.489
AC:
21843
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
20423
AN:
26104
East Asian (EAS)
AF:
0.560
AC:
22220
AN:
39682
South Asian (SAS)
AF:
0.673
AC:
58036
AN:
86176
European-Finnish (FIN)
AF:
0.766
AC:
40678
AN:
53120
Middle Eastern (MID)
AF:
0.794
AC:
4227
AN:
5326
European-Non Finnish (NFE)
AF:
0.730
AC:
809735
AN:
1109268
Other (OTH)
AF:
0.709
AC:
42744
AN:
60246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
17081
34162
51242
68323
85404
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19848
39696
59544
79392
99240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.655
AC:
99667
AN:
152110
Hom.:
33489
Cov.:
33
AF XY:
0.653
AC XY:
48561
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.532
AC:
22048
AN:
41480
American (AMR)
AF:
0.556
AC:
8510
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.770
AC:
2675
AN:
3472
East Asian (EAS)
AF:
0.539
AC:
2778
AN:
5158
South Asian (SAS)
AF:
0.660
AC:
3184
AN:
4824
European-Finnish (FIN)
AF:
0.775
AC:
8226
AN:
10610
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.736
AC:
49997
AN:
67952
Other (OTH)
AF:
0.666
AC:
1407
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1689
3377
5066
6754
8443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.711
Hom.:
7129
Bravo
AF:
0.636
Asia WGS
AF:
0.587
AC:
2046
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 04, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glycogen storage disease, type II Benign:3
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 19, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.2
DANN
Benign
0.35
PhyloP100
-0.19
BranchPoint Hunter
3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2304844; hg19: chr17-78084507; API